Biotech Archives - Page 60 of 89 - Boston Life Sciences Times

Iterative Health Raises $77 Million to Expand Clinical Research Network

April 30, 2026

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

April 28, 2026

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

THIS WEEK'S STORIES

Seaport Therapeutics Adds Biotech Leader Sharon Mates to Board

April 27, 2026

Motif Neurotech Wins FDA Clearance to Launch First Human Trial for Depression Implant

April 27, 2026

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

April 29, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

Charles River Launches Rat IVF Services to Support Research Model Programs

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

Boston Cell Standards Advances Toward FDA Qualification for Cancer Testing Platform

Seaport Therapeutics Adds Biotech Leader Sharon Mates to Board

4Moving Biotech Secures FDA Fast Track Status for Experimental Knee Osteoarthritis Drug

Most Read

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Johnson & Johnson Names Ryan Koors Vice President of Investor Relations

Moleculent Raises $20 Million to Expand Functional Profiling Platform

Komodo Health Names Paul Thomas Chief Financial Officer

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Seaport Therapeutics Adds Biotech Leader Sharon Mates to Board

Motif Neurotech Wins FDA Clearance to Launch First Human Trial for Depression Implant

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

POPULAR CATEGORY

ABOUT US

FOLLOW US